GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SXTP · Sep 30, 2025

60 DEGREES PHARMACEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001554855-25-002032General Corporate
Debt relative to revenue11thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.debt_to_revenue

34.28% · OPTIONAL · VALID

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.28% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generation100thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-481.96% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

223.45% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure11thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

120.43% · OPTIONAL · VALID

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

-22.87% · CORE · NOT_ENOUGH_HISTORY

Operating margin100thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.operating_margin

-531.42% · CORE · VALID

R&D intensity0thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

185.05% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

18.05% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
148.61%
Current
34.28%
Delta
-114.34%
Capex Intensity Decreased
Previous
46.89%
Current
2.28%
Delta
-44.60%
Cash Generation Increased
Previous
-1436.74%
Current
-481.96%
Delta
954.78%
Growth Increased
Previous
-19.24%
Current
223.45%
Delta
242.68%
Inventory Pressure Decreased
Previous
792.04%
Current
120.43%
Delta
-671.61%
Margin Decreased
Previous
50.41%
Current
-22.87%
Delta
-73.28%
Profitability Increased
Previous
-1590.01%
Current
-531.42%
Delta
1058.58%
R And D Intensity Decreased
Previous
247.58%
Current
185.05%
Delta
-62.53%
Sbc Intensity Decreased
Previous
77.89%
Current
18.05%
Delta
-59.84%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.